Table: begin end state 1 20 cytoplasmic 21 42 transmembrane 43 47 non-cytoplasmic 48 67 transmembrane 68 87 cytoplasmic 88 110 transmembrane 111 127 non-cytoplasmic 128 146 transmembrane 147 156 cytoplasmic 157 181 transmembrane 182 201 non-cytoplasmic 202 222 transmembrane 223 242 cytoplasmic 243 264 transmembrane 265 288 non-cytoplasmic 289 310 transmembrane 311 333 cytoplasmic 334 356 transmembrane 357 361 non-cytoplasmic 362 382 transmembrane 383 402 cytoplasmic 403 425 transmembrane 426 430 non-cytoplasmic 431 448 transmembrane 449 460 cytoplasmic
Input: >PP_4106 FitnessBrowser__Putida:PP_4106 MASQDNKKQRSLQHGLTSRQVSMISIAGIIGAGLFIGSSNAIATAGPAILISYAMTGLLV LLVMRMLGEMAIANPNSGSFSTYASEAIGPWAGFTIGWLYWWFWVLIIPVEAIAGADILH AYFPGVPSWLFAFLIMLVLSGTNLVSVKNFGAFEYWFALVKVVAIIGFIGVCTLAVFGFW PLAEVSGVSRLWDSGGFMPNGFGTVLGGVLITIFSFFGAEIVTIAADETANPKDKIRRAT NLVVYRIAIFYLASIFLVVSLVAWNDPGLKAVGSFQRVLEVLNVPGAKLLVDLVVLVAVT SCMNSGLYTASRMLYSLGARGQALSVTKRISGSGVPTVAVIFSTLAGFAGCFVNYVFPGK VFGFLLSTTGAIALLVYLVIAVSQLRMRARAEREGRPLELKMWLFPWLTWLVIGTIVMVL GYMLFSDAYRYETLMTAGVTAFILLVSLTQRRAKMVAQTA
Or try the official Phobius web server, which has a different display
Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server